These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33297605)

  • 21. Zyxin (ZYX) promotes invasion and acts as a biomarker for aggressive phenotypes of human glioblastoma multiforme.
    Wen XM; Luo T; Jiang Y; Wang LH; Luo Y; Chen Q; Yang K; Yuan Y; Luo C; Zhang X; Yan ZX; Fu WJ; Tan YH; Niu Q; Xiao JF; Chen L; Wang J; Huang JF; Cui YH; Zhang X; Wang Y; Bian XW
    Lab Invest; 2020 Jun; 100(6):812-823. PubMed ID: 31949244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential gene expression in peritumoral brain zone of glioblastoma: role of SERPINA3 in promoting invasion, stemness and radioresistance of glioma cells and association with poor patient prognosis and recurrence.
    Nimbalkar VP; Kruthika BS; Sravya P; Rao S; Sugur HS; Verma BK; Chickabasaviah YT; Arivazhagan A; Kondaiah P; Santosh V
    J Neurooncol; 2021 Mar; 152(1):55-65. PubMed ID: 33389566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and clinical significance of CPS1 in glioblastoma multiforme.
    Wu G; Yan Y; Zhou Y; Wang X; Wei J; Chen X; Lin W; Ou C; Zhou J; Xu Z
    Curr Res Transl Med; 2019 Nov; 67(4):123-128. PubMed ID: 31492588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcription factor 7 functions as an unfavorable prognostic marker of glioblastoma multiforme by promoting proliferation by upregulating c-Myc.
    Su Y; Wang Y; Sun Y; Zhou X
    Neuroreport; 2018 Jun; 29(9):745-752. PubMed ID: 29642232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The PDK1/c‑Jun pathway activated by TGF‑β induces EMT and promotes proliferation and invasion in human glioblastoma.
    Luo D; Xu X; Li J; Chen C; Chen W; Wang F; Xie Y; Li F
    Int J Oncol; 2018 Nov; 53(5):2067-2080. PubMed ID: 30106127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Up-regulated circular RNA hsa_circ_0067934 contributes to glioblastoma progression through activating PI3K-AKT pathway.
    Xin J; Zhang XY; Sun DK; Tian LQ; Xu P
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3447-3454. PubMed ID: 31081099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA HOXA-AS3 promotes the malignancy of glioblastoma through regulating miR-455-5p/USP3 axis.
    Chen W; Li Q; Zhang G; Wang H; Zhu Z; Chen L
    J Cell Mol Med; 2020 Oct; 24(20):11755-11767. PubMed ID: 32918360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of CD147 in patients with glioblastoma.
    Yang M; Yuan Y; Zhang H; Yan M; Wang S; Feng F; Ji P; Li Y; Li B; Gao G; Zhao J; Wang L
    J Neurooncol; 2013 Oct; 115(1):19-26. PubMed ID: 23925827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and prognostic value of the transcription factors EGR1 and EGR3 in gliomas.
    Knudsen AM; Eilertsen I; Kielland S; Pedersen MW; Sørensen MD; Dahlrot RH; Boldt HB; Munthe S; Poulsen FR; Kristensen BW
    Sci Rep; 2020 Jun; 10(1):9285. PubMed ID: 32518380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways.
    Mu N; Gu J; Liu N; Xue X; Shu Z; Zhang K; Huang T; Chu C; Zhang W; Gong L; Zhao H; Jia B; Gao D; Shang L; Zhang W; Guo Q
    Theranostics; 2018; 8(6):1527-1539. PubMed ID: 29556339
    [No Abstract]   [Full Text] [Related]  

  • 31. miR-25 promotes glioblastoma cell proliferation and invasion by directly targeting NEFL.
    Peng G; Yuan X; Yuan J; Liu Q; Dai M; Shen C; Ma J; Liao Y; Jiang W
    Mol Cell Biochem; 2015 Nov; 409(1-2):103-11. PubMed ID: 26209061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets.
    Hoelzinger DB; Mariani L; Weis J; Woyke T; Berens TJ; McDonough WS; Sloan A; Coons SW; Berens ME
    Neoplasia; 2005 Jan; 7(1):7-16. PubMed ID: 15720813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Annexin 2A sustains glioblastoma cell dissemination and proliferation.
    Maule F; Bresolin S; Rampazzo E; Boso D; Della Puppa A; Esposito G; Porcù E; Mitola S; Lombardi G; Accordi B; Tumino M; Basso G; Persano L
    Oncotarget; 2016 Aug; 7(34):54632-54649. PubMed ID: 27429043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme.
    Tan SK; Pastori C; Penas C; Komotar RJ; Ivan ME; Wahlestedt C; Ayad NG
    Mol Cancer; 2018 Mar; 17(1):74. PubMed ID: 29558959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
    Guan Y; He Y; Lv S; Hou X; Li L; Song J
    J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing.
    Fan F; Zhang H; Dai Z; Zhang Y; Xia Z; Cao H; Yang K; Hu S; Guo Y; Ding F; Cheng Q; Zhang N
    Cell Oncol (Dordr); 2021 Aug; 44(4):917-935. PubMed ID: 34142341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
    Liang Y; Bollen AW; Aldape KD; Gupta N
    BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary glioblastoma multiforme tumors and recurrence : Comparative analysis of the danger signals HMGB1, HSP70, and calreticulin.
    Muth C; Rubner Y; Semrau S; Rühle PF; Frey B; Strnad A; Buslei R; Fietkau R; Gaipl US
    Strahlenther Onkol; 2016 Mar; 192(3):146-55. PubMed ID: 26646311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of osteosarcoma cell invasion by chemotherapy is mediated by urokinase plasminogen activator activity via up-regulation of EGR1.
    Matsunoshita Y; Ijiri K; Ishidou Y; Nagano S; Yamamoto T; Nagao H; Komiya S; Setoguchi T
    PLoS One; 2011 Jan; 6(1):e16234. PubMed ID: 21283769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-106a is an independent prognostic marker in patients with glioblastoma.
    Zhao S; Yang G; Mu Y; Han D; Shi C; Chen X; Deng Y; Zhang D; Wang L; Liu Y; Hou X; Wang C; Wu J; Liu H; Wang L; Zhang G; Qi J; Fang X; Shi C; Ai J
    Neuro Oncol; 2013 Jun; 15(6):707-17. PubMed ID: 23416698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.